These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 10509792)

  • 1. An illustration of the clinical relevance of detecting human antimouse antibody interference by affinity chromatography.
    Koper NP; Massuger LF; Thomas CM; Beyer C; Crooy MJ
    Eur J Obstet Gynecol Reprod Biol; 1999 Oct; 86(2):203-5. PubMed ID: 10509792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of IgG and IgM human anti-mouse antibodies (HAMA) interference in CA 125 measurements using affinity chromatography.
    Koper NP; Thomas CM; Massuger LF; Segers MF; Olthaar AJ; Verbeek AL
    Clin Chem Lab Med; 1998 Jan; 36(1):23-8. PubMed ID: 9594082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BR-MA, OM-MA, GI-MA and CEA: clinical evaluation using the IMMULITE analyzer.
    van Dalen A
    Tumour Biol; 1999; 20(3):117-29. PubMed ID: 10213919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IMMULITE OM-MA assay: a useful diagnostic tool in patients with benign and malignant ovarian tumors.
    Gebauer G; Rieger M; Jäger W; Lang N
    Anticancer Res; 1999; 19(4A):2535-6. PubMed ID: 10470190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for interaction of human anti-idiotypic antibodies with CA 125 determination in a patient after radioimmunodetection.
    Reinsberg J; Heydweiller A; Wagner U; Pfeil K; Oehr P; Krebs D
    Clin Chem; 1990 Jan; 36(1):164-7. PubMed ID: 2297919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different efficacy of various blocking reagents to eliminate interferences by human antimouse antibodies with a two-site immunoassay.
    Reinsberg J
    Clin Biochem; 1996 Apr; 29(2):145-8. PubMed ID: 8601323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IMx CA 125, an automated microparticle enzyme immunoassay: technical characteristics and clinical usefulness after recalibration.
    Mogensen O; Mogensen B
    Scand J Clin Lab Invest; 1995 Jul; 55(4):289-94. PubMed ID: 7569730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interference by human anti-mouse antibodies in CA 125 assay after immunoscintigraphy: anti-idiotypic antibodies not neutralized by mouse IgG but removed by chromatography.
    Turpeinen U; Lehtovirta P; Alfthan H; Stenman UH
    Clin Chem; 1990 Jul; 36(7):1333-8. PubMed ID: 2372947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human anti-murine antibody interference in measurement of carcinoembryonic antigen assessed with a double-antibody enzyme immunoassay.
    Price T; Beatty BG; Beatty JD; McNally AJ
    Clin Chem; 1991 Jan; 37(1):51-7. PubMed ID: 1988209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of four 'second generation' immunoassay systems to determine CA 125 in serum by using a graphical approach to method comparison analysis.
    Koper NP; Thomas CM; Massuger LF; Segers MF; Kiemeney LA; Verbeek AL
    Eur J Clin Chem Clin Biochem; 1997 Aug; 35(8):617-23. PubMed ID: 9298352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondii-specific immunoglobulin G (IgG) and IgM and the IgG avidity index.
    Petersen E; Borobio MV; Guy E; Liesenfeld O; Meroni V; Naessens A; Spranzi E; Thulliez P
    J Clin Microbiol; 2005 Apr; 43(4):1570-4. PubMed ID: 15814967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confirmation of a false-positive result in CA 125 immunoradiometric assay caused by human anti-idiotypic immunoglobulin.
    Klug TL; Green PJ; Zurawski VR; Davis HM
    Clin Chem; 1988 Jun; 34(6):1071-6. PubMed ID: 2454168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific interference with the determination of the tumour-associated glycoprotein 72 by human anti-idiotypic antibodies formed after treatment with the anti-tumour-associated glycoprotein 72 antibody B72.3.
    Reinsberg J; Gast B; Schmolling J; Wagner U; Krebs D
    Eur J Clin Chem Clin Biochem; 1994 Sep; 32(9):691-6. PubMed ID: 7865625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical and clinical performance of improved Abbott IMx CA 125 assay: comparison with Abbott CA 125 RIA.
    Thomas CM; Massuger LF; Segers MF; Schijf CP; Doesburg WH; Wobbes T
    Clin Chem; 1995 Feb; 41(2):211-6. PubMed ID: 7874773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solving the problem of antibody interference in commercial "sandwich"-type immunoassays of carcinoembryonic antigen.
    Hansen HJ; LaFontaine G; Newman ES; Schwartz MK; Malkin A; Mojzisik K; Martin EW; Goldenberg DM
    Clin Chem; 1989 Jan; 35(1):146-51. PubMed ID: 2642761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Lumipulse G TP-N Chemiluminescent Immunoassay as a Syphilis Screening Test.
    Ortiz DA; Loeffelholz MJ
    J Clin Microbiol; 2017 Nov; 55(11):3236-3241. PubMed ID: 28878003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A.
    Gruber R; van Haarlem LJ; Warnaar SO; Holz E; Riethmüller G
    Cancer Res; 2000 Apr; 60(7):1921-6. PubMed ID: 10766181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nonspecific reacting materials that interferes tacrolimus assay by ACMIA].
    Abei M; Yagi M; Watanabe T; Sugimoto K; Tanno Y; Kaito K
    Rinsho Byori; 2013 Nov; 61(11):983-8. PubMed ID: 24450102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a biosensor-based immunogenicity assay capable of blocking soluble drug target interference.
    Weeraratne DK; Lofgren J; Dinnogen S; Swanson SJ; Zhong ZD
    J Immunol Methods; 2013 Oct; 396(1-2):44-55. PubMed ID: 23933325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring cancer antigen 125 in serum of ovarian cancer patients after administration of 131I-labeled F(ab')2 fragments of OC125 antibody.
    Reinsberg J; Schultes B; Wagner U; Krebs D
    Clin Chem; 1993 May; 39(5):891-6. PubMed ID: 8485883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.